Abbott Laboratories (ABT)

pos +0.00
Today's Range: 0.00 - 0.00 | ABT Avg Daily Volume: 0
Last Update: 11/24/15 - 4:00 PM EST
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $45.45
52 Week Range: $39.00 - $51.74
Oustanding Shares: 1,491,720,000
Market Cap: 67,798,674,000
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for ABT:
Revenue 0.00B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $0.62 $0.50 $2.16 $2.39
Number of Analysts 12 6 15 15
High Estimate $0.64 $0.52 $2.18 $2.46
Low Estimate $0.61 $0.49 $2.15 $2.30
Prior Year $0.71 $0.47 $2.28 $2.16
Growth Rate (Year over Year) -13.38% 6.03% -5.47% 11.01%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Nov 13, 2015 | 7:04 AM EST
ABT was downgraded from Buy to Neutral, Goldman Sachs said. Valuation call, based on a $48 price target. 

The Book of Boockvar Real Money Pro($)

Peter Boockvar looks at China, the European Central Bank and the Bank of Japan this morning:
Oct 07, 2015 | 7:09 AM EDT
ABT was upgraded to Overweigt, Barclays said. $52 price target. Valuation call, after the stock is down 18% over the past six weeks.&nb...
Before you sell them, ask yourself at what multiple you sell.

AbbVie Has More Downside to Go Real Money Pro($)

The stock has shown awful relative strength.
IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..
This market is almost entirely special situation.
Duke Energy's recent increase puts its payout at the high end of the industry range.
As health-care stocks rally, it's time for politicians to move on.

Columnist Conversations

Market holding up very well given news of downed Russian jet over Turkey today. However, it is still a very b...
Yesterday's Saudi announcement coupled with this morning's geopolitical tensions have combined to goose oil pr...
These refiners are stretching out here, the best turnover is in Valero, and we have seen some big option flow ...
Cracker Barrel is getting pounded today following this morning's earnings report. The stock is off over 7...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.